Cargando…
Enhancing Targeted Therapy in Breast Cancer by Ultrasound-Responsive Nanocarriers
Currently, the response to cancer treatments is highly variable, and severe side effects and toxicity are experienced by patients receiving high doses of chemotherapy, such as those diagnosed with triple-negative breast cancer. The main goal of researchers and clinicians is to develop new effective...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053544/ https://www.ncbi.nlm.nih.gov/pubmed/36982548 http://dx.doi.org/10.3390/ijms24065474 |